Literature DB >> 32976958

Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.

Yuwei Yang1, Jing Chen1, Qin Gao1, Xin Shan1, Jie Wang1, Zhiyang Lv2.   

Abstract

Ginkgolide B (GB), a main constituent of Ginkgo biloba extracts, reduces hepatic lipid accumulation and ameliorates nonalcoholic fatty liver disease (NAFLD) in obese mice, but the potential mechanism is unclear. Here we investigated the attenuated effects of GB on the disorder of lipid metabolism, oxidative stress and iron deposition in NAFLD and its potential mechanism associated with ferroptosis. Our preliminary research focused on high fat diet (HFD)-induced ApoE-/-mice gavaged with GB (20 and 30 mg kg-1•d-1, approximately equal to the human dose of 2 and 3 mg kg-1•d-1, respectively) and palmitic acid and oleic acid (PA/OA)-induced HepG2 cells treated with GB (4, 8, 16 μg/mL), respectively. Hepatic injury was assessed via biochemical, histopathological and immunohistochemical evaluations. In order to examine the mechanism of GB on ferroptosis-regulated pathway, we analyzed the expression levels of ferroptosis-related proteins, including nuclear factor erythroid 2 (Nrf2), glutathione peroxidase 4 (GPX4), heme oxygenase-1 (HO-1), transferrin receptor-1 (TFR1) and ferritin heavy chain-1 (FTH1) in vivo and vitro experiments by Western blotting. In order to further verify the correlation pathway of ferroptosis, after Nrf2 short hairpin RNA interference, we analyzed the effects of GB on Nrf2 pathway. Both HFD-fed mice and PA/OA-induced HepG2 cells displayed ferroptosis-based panel of biomarkers such as iron overload with the up-regulation of TFR1 and the down-regulation of FTH1, lipid peroxidation and inhibition of Nrf2 activity, which further induced GPX4 and HO-1 levels. Remarkably, after Nrf2 interference, GB treatment significantly increased Nrf2 expression, indicating that GB exerted anti-ferroptosis effects by activation of Nrf2 pathway. Our results are preliminarily illustrated that GB treatment has a specific effect on lipid accumulation and oxidative stress caused ferroptosis in NAFLD, possibly through Nrf2 signaling pathway.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ferroptosis; Ginkgolide B; Nonalcoholic fatty liver disease; Nrf2 signaling pathway

Year:  2020        PMID: 32976958     DOI: 10.1016/j.tox.2020.152599

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  11 in total

Review 1.  A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?

Authors:  Taís Menezes do Moinho; Sandro Leão Matos; Carla R O Carvalho
Journal:  J Mol Med (Berl)       Date:  2022-01-07       Impact factor: 4.599

Review 2.  The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases.

Authors:  Yijing Ren; Siyue Li; Zixuan Song; Qiuping Luo; Yingying Zhang; Hao Wang
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

Review 3.  Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges.

Authors:  Xiaoxi Zhou; Yadong Fu; Wei Liu; Yongping Mu; Hua Zhang; Jiamei Chen; Ping Liu
Journal:  Front Mol Biosci       Date:  2022-06-03

Review 4.  Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?

Authors:  Jia-Yue Duan; Xiao Lin; Feng Xu; Su-Kang Shan; Bei Guo; Fu-Xing-Zi Li; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Li-Min Lei; Wen-Lu Ou-Yang; Yun-Yun Wu; Ke-Xin Tang; Ling-Qing Yuan
Journal:  Front Cell Dev Biol       Date:  2021-07-09

Review 5.  The Emerging Role of Ferroptosis in Liver Diseases.

Authors:  Si Chen; Jun-Yao Zhu; Xin Zang; Yong-Zhen Zhai
Journal:  Front Cell Dev Biol       Date:  2021-12-14

Review 6.  The Nrf2 Pathway in Liver Diseases.

Authors:  Jiaming Zhou; Qiuxian Zheng; Zhi Chen
Journal:  Front Cell Dev Biol       Date:  2022-02-10

Review 7.  Research Progress of Ferroptosis in Adiposity-Based Chronic Disease (ABCD).

Authors:  Huijun Du; Xiaoying Ren; Juncai Bai; Wei Yang; Yunan Gao; Shuang Yan
Journal:  Oxid Med Cell Longev       Date:  2022-04-23       Impact factor: 7.310

Review 8.  Ferroptosis and Its Role in Chronic Diseases.

Authors:  Wenli Hu; Kehong Liang; Hong Zhu; Chong Zhao; Hongbo Hu; Shutao Yin
Journal:  Cells       Date:  2022-06-27       Impact factor: 7.666

Review 9.  Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases.

Authors:  Zhenzhen Zhai; Yanxin Huang; Yawei Zhang; Lili Zhao; Wen Li
Journal:  Antioxidants (Basel)       Date:  2022-08-12

Review 10.  Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.

Authors:  Yi Guo; Chanjun Lu; Ke Hu; Chuanqi Cai; Weici Wang
Journal:  Biomolecules       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.